Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI matches radiologists in reading chest X-Rays, study finds

NCT ID NCT05963945

Diagnosis Sponsor: Carebot s.r.o. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an AI tool called Carebot AI CXR to see how well it spots lung problems like collapsed lungs, nodules, and fluid buildup on chest X-rays. Researchers compared the AI's performance to that of human radiologists using 956 patient X-rays. The goal was to see if the AI could help in everyday hospital practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

956 people

The number who actually took part.

Started

Oct 2022

Finished

Mar 2023

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient's Sex Female: 480 (50.21 %) Male: 474 (49.58 %) Unspecified: 2 (0.21 %) Patient's Age 18-30: 58 (6.07 %) 31-50: 163 (17.05 %) 51-70: 366 38.28 %) 70+: 369 (38.60 %)

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Hospital patients \> 18 years who were referred for chest radiography October 18th, 2022, and November 17th, 2022 at the Radiodiagnostic Department of the Havířov Hospital, p.o. Exclusion Criteria: * Patients \< 18 years * Chest X-ray images in lateral positions * Duplicated chest X-ray images

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atelectasis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cardiomegaly middle lobe syndrome Pleural Effusion pneumothorax Pulmonary Atelectasis pulmonary coin lesion Subcutaneous Emphysema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atelectasis Cardiomegaly Consolidation Pleural effusion Pneumothorax Pulmonary nodule, solitary Subcutaneous emphysema

Contacts and locations

Locations

  • Nemocnice Havířov, p. o.

    Havířov, 73601, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.